Dr Benjamin Mullin is a Senior Scientist based at Sir Charles Gairdner Hospital in Western Australia. His research interests include the genetics of complex disease, particularly endocrine conditions and diseases of the skeleton. Dr Mullin has worked on several genome-wide association studies for osteoporosis-risk traits and recently played a leading role in the generation of a unique osteoclast-specific multi-omics resource for study of the genetics of bone disease. This resource has successfully been used to identify several GWAS effector genes for osteoporosis, osteoarthritis and Paget’s disease of bone.